HC5 Stock Chart & Stats
€18.46
€0.26(1.35%)
At close: 4:00 PM EDT
€18.46
€0.26(1.35%)
Day’s Range― - ―
52-Week Range€13.30 - €20.03
Previous CloseN/A
Volume0.00
Average Volume (3M)3.00
Market Cap
€11.85B
Enterprise Value€25.02B
Total Cash (Recent Filing)€1.63B
Total Debt (Recent Filing)€10.32B
Price to Earnings (P/E)54.0
Beta0.22
Next Earnings
Nov 02, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.35
Shares Outstanding689,527,300
10 Day Avg. Volume0
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG Ratio-2.23
Price to Book (P/B)1.49
Price to Sales (P/S)3.97
P/FCF Ratio8.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€20.00Price Target Upside8.34% Upside
Rating ConsensusHold
Number of Analyst Covering13
EPS Forecast (FY)0.4
Revenue Forecast (FY)€2.68B
Bulls Say, Bears Say
Bulls Say
Balance Sheet And LiquidityImproved leverage, substantial liquidity, and recent debt repayment strengthen Healthpeak’s financial flexibility. This supports ongoing investment, capital recycling, and shareholder returns while reducing dependence on unfavorable financing conditions over the next several quarters.
Outpatient Leasing StrengthStrong outpatient leasing, high retention, positive re-leasing spreads, and occupancy near 91% support durable recurring cash flow. These metrics indicate healthy demand for Healthpeak’s medical office assets and provide a foundation for sustained same-store NOI growth.
Senior Housing GrowthJanus’s strong revenue, EBITDA, occupancy, and NOI performance adds a meaningful growth engine within Healthpeak’s healthcare real estate portfolio. Continued senior housing operating improvement can diversify earnings and support cash-flow expansion beyond traditional rent growth.
Bears Say
Lab Occupancy Remains WeakLife science properties remain less fully utilized than outpatient assets, leaving a substantial vacancy burden to overcome. Until absorption improves, lab NOI growth may remain delayed and the portfolio could require additional leasing incentives or investment to regain momentum.
Redevelopment Capital NeedsHigher redevelopment spending can reduce near-term returns and increase the capital required to convert vacant or outdated space. These investments may ultimately improve occupancy, but they create execution demands and can constrain cash available for other portfolio priorities.
Cash-flow ConsistencyHealthpeak continues to generate positive cash, but the sharp decline in free-cash-flow growth and weaker conversion from earnings indicate less predictable cash generation. Persistent volatility could limit internally funded investment and make capital allocation more sensitive to operating conditions.
Healthpeak Properties News
HC5 FAQ
What was Healthpeak Properties’s price range in the past 12 months?
Healthpeak Properties lowest stock price was €13.30 and its highest was €20.03 in the past 12 months.
What is Healthpeak Properties’s market cap?
Healthpeak Properties’s market cap is €11.85B.
When is Healthpeak Properties’s upcoming earnings report date?
Healthpeak Properties’s upcoming earnings report date is Nov 02, 2026 which is in 22 days.
How were Healthpeak Properties’s earnings last quarter?
Healthpeak Properties released its earnings results on Aug 04, 2026. The company reported €0.071 earnings per share for the quarter, beating the consensus estimate of €0.025 by €0.046.
Is Healthpeak Properties overvalued?
According to Wall Street analysts Healthpeak Properties’s price is currently Undervalued.
Does Healthpeak Properties pay dividends?
Healthpeak Properties does not currently pay dividends.
What is Healthpeak Properties’s EPS estimate?
Healthpeak Properties’s EPS estimate is 0.06.
How many shares outstanding does Healthpeak Properties have?
Healthpeak Properties has 689,527,300 shares outstanding.
What happened to Healthpeak Properties’s price movement after its last earnings report?
Healthpeak Properties reported an EPS of €0.071 in its last earnings report, beating expectations of €0.025. Following the earnings report the stock price went up 1.016%.
Which hedge fund is a major shareholder of Healthpeak Properties?
Currently, no hedge funds are holding shares in DE:HC5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Healthpeak Properties Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€20.00 (8.34% Upside)
€20.00 (8.34% Upside)
Blogger Sentiment
Bullish
DE:HC5 Sentiment 80%
Sector Average 63%
Sector Average 63%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.85%
12-Months-Change
Fundamentals
Return on Equity
3.30%
Trailing 12-Months
Asset Growth
9.44%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Healthpeak Properties
Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.
HC5 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted meaningful operational progress: strong balance sheet metrics (net debt/EBITDA 4.7x), sizable liquidity, large JV partnerships (Brookfield/Blackstone) that raise $1B+ in proceeds while preserving control, strong outpatient leasing (1.2M SF in Q2; occupancy to 90.7%), lab leasing momentum and occupancy improvement (78.5%, +140 bps YTD), and significant senior housing/Janus performance (45% revenue growth, 34% adjusted EBITDA growth). Challenges remain, notably lab occupancy still below peak, selective elevated CapEx needs for redevelopments, elevated borrowing costs limiting leverage options, cautious tenant timelines, and only a modest FFO guidance raise. Overall the positive operational momentum, strategic partnerships, and strong liquidity and balance sheet outweigh the remaining execution and market risks.View all DE:HC5 earnings summariesHC5 Revenue Breakdown
76.41% Rental and related revenues
21.40% Resident fees and services
2.19% Interest income and other

HC5 Stock 12 Month Forecast
Average Price Target
€20.00
▲(8.34% Upside)
Technical Analysis
Omega Healthcare
―
Sabra Healthcare REIT
―
Medical Properties Trust
―
Healthcare Realty Trust
―
National Healthcare Properties
―










